Answer
Yes, retinal vasculitis and retinal occlusive vasculitis have been spontaneously reported after marketing with faricimab (Vabysmo), but their frequency cannot be reliably estimated.
Sources for this answer
- Vabysmo 120 mg/mL solution for injectionRoche Products Limited · emc · SmPC §4.8 Undesirable effects · Version 7Document updated
Sources checked